U.S. Stock Earnings Reports & Market News
CELH FY2025 Q2 Financial Results: Revenue Increased 84%, Net Income $99.9M
Executive Summary
In the second quarter of fiscal year 2025, Celsius Holdings, Inc. demonstrated robust revenue growth, with a 84% increase compared to the same period last year, driven primarily by expanded sales channels and recent acquisitions. Net income reached $99.9 million, reflecting strong operational performance and effective cost management. The company’s balance sheet shows significant asset growth, notably in goodwill and intangible assets following the acquisition of Alani Nu. Liquidity remains healthy with over $615 million in cash and cash equivalents, while leverage has increased due to recent debt financing. Overall, CELH exhibits a positive growth trajectory with strategic acquisitions fueling long-term expansion.
Key Metrics
| Metric | Q2 FY2025 | Q2 FY2024 | Change |
|---|---|---|---|
| Revenue (USD) | 739.3M | 402.0M | +84% |
| Net Income (USD) | 99.9M | 79.8M | +25% |
| Gross Profit (USD) | 380.9M | 209.1M | +82% |
| Cash & Equivalents (USD) | 615.2M | 890.2M | -31% |
| Total Assets (USD) | 3.795B | 1.767B | +115% |
| Total Debt (USD) | 862.9M | 0 | Increase due to recent debt issuance |
Management Discussion and Analysis
CELH’s revenue growth of 84% in Q2 FY2025 is primarily attributable to the successful integration of Alani Nu, which contributed approximately $301.2 million in revenue during the period. The company’s strategic partnership with PepsiCo continues to bolster distribution and brand visibility, accounting for over 33% of sales. Gross margins improved significantly, reflecting economies of scale and favorable product mix. Operating expenses increased proportionally with revenue, supporting marketing initiatives and expansion efforts. Net income rose by 25%, demonstrating operational leverage and effective cost controls. The balance sheet shows asset growth driven by goodwill and intangible assets, with total assets increasing by 115%. Liquidity remains strong, although cash balances decreased due to debt repayment and acquisition costs. Leverage has increased with the issuance of a $900 million term loan to finance acquisitions, positioning the company for long-term growth.
Income Statement Analysis
Revenue for Q2 FY2025 was $739.3 million, up 84% from $402.0 million in the same period last year, mainly due to the acquisition of Alani Nu and increased distribution channels. Gross profit increased by 82% to $380.9 million, with gross margin expanding slightly due to favorable product mix and scale efficiencies. Operating expenses grew by 107%, reflecting increased marketing and administrative costs associated with expansion activities. Operating income stood at $143 million, a substantial increase from last year’s $94.2 million. Net income reached $99.9 million, a 25% increase YoY, with earnings per share (diluted) at $0.33, up from $0.28 in Q2 FY2024. The company’s profitability remains strong, supported by revenue growth and margin expansion.
Balance Sheet Analysis
As of June 30, 2025, CELH reported total assets of $3.795 billion, a 115% increase driven by the acquisition of Alani Nu and asset revaluations. Cash and cash equivalents decreased to $615.2 million from $890.2 million, primarily due to debt repayment and acquisition costs. Accounts receivable increased by 81%, reflecting higher sales volume, with receivables at $490.4 million. Inventories grew by 76%, totaling $230 million, aligned with increased production and distribution. Goodwill increased to $802.2 million, mainly from the Alani Nu acquisition, which contributed approximately $728.9 million in goodwill. Total liabilities rose to $1.703 billion, with long-term debt of $862.9 million, reflecting recent debt issuance. Shareholders’ equity increased to $1.266 billion, supported by retained earnings and additional paid-in capital. The company’s liquidity position remains robust, with a current ratio of approximately 2.1.
Cash Flow Analysis
Operating cash flow for the six months ended June 30, 2025, was $147.1 million, slightly lower than $174.3 million in the prior year, due to increased working capital requirements from inventory buildup. Investing activities included a $1.256 billion outflow for the Alani Nu acquisition, offset by cash received from asset sales and property purchases. Capital expenditures were approximately $15.2 million, primarily for manufacturing capacity expansion. Financing activities included proceeds of $900 million from the new term loan, used to fund acquisitions, and dividend payments of $6.8 million on Series A Preferred Stock. The company also repurchased shares and paid down debt, maintaining a balanced approach to capital management. Overall, CELH maintains strong cash flow generation capacity, supporting growth initiatives and shareholder returns.
Ratios & DuPont Analysis
Net profit margin stands at 13.5%, reflecting efficient operations amid rapid growth. Return on assets (ROA) is approximately 5.7%, driven by high net income relative to total assets. Return on equity (ROE) is approximately 7.9%, supported by increased shareholders’ equity and net income. Asset turnover ratio is 0.29, indicating effective utilization of assets to generate revenue. The equity multiplier is 2.99, reflecting increased leverage from debt issuance. The DuPont analysis underscores the company’s strong profitability and leverage, with margin expansion and asset efficiency contributing to overall performance.
Risk Factors
CELH faces regulatory risks related to health claims and advertising, especially following recent legal and SEC inquiries. Market risks include intense competition in the functional beverage sector and changing consumer preferences. Operational risks involve supply chain disruptions and integration challenges from acquisitions. Financial risks stem from increased leverage and debt servicing obligations. Macro risks include inflation, currency fluctuations, and economic downturns affecting consumer spending. The company’s strategic focus on innovation and partnerships aims to mitigate these risks, but investors should remain cautious of potential volatility and regulatory developments.
Notes & Additional Commentary
Unusual items in this period include a non-cash impairment charge of $0.5 million related to the Func Foods brand. Acquisition-related costs totaled approximately $24.8 million, impacting operating expenses. The company’s aggressive growth strategy, including the recent Alani Nu acquisition, positions it for long-term expansion but introduces integration and execution risks. The increase in debt levels warrants attention to leverage ratios and debt service capacity. Overall, CELH’s performance reflects successful execution of strategic initiatives, with a positive outlook supported by strong revenue growth and brand diversification.
Investment Implications
Short-term opportunities include leveraging the Pepsi partnership and expanding distribution channels to sustain revenue momentum. Long-term risks involve integration challenges and increased leverage, which could pressure margins if not managed effectively. The company’s focus on innovation and strategic acquisitions suggests a growth-oriented outlook, but investors should monitor regulatory developments and competitive dynamics. A balanced approach, considering both growth prospects and operational risks, is recommended for long-term investors seeking exposure to the expanding functional beverage market.
